$AQU
Aquaron Acquisition Corp.

2023 Q1 Form 10-K Financial Statement

#000121390023024748 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $100.00
YoY Change
Gross Profit -$100.00
YoY Change
Gross Profit Margin
Selling, General & Admin $350.0K $210.0K $220.0K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $350.0K $210.0K $220.0K
YoY Change
Operating Profit -$352.8K -$210.1K -$221.0K
YoY Change 16365.05%
Interest Expense $590.0K $440.0K $440.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $240.0K $220.0K $220.0K
YoY Change
Income Tax $46.59K $50.00K $51.75K
% Of Pretax Income 19.41% 22.73% 23.52%
Net Earnings $151.8K $170.0K $164.1K
YoY Change -7183.81%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.02 $0.02 $0.02
COMMON SHARES
Basic Shares Outstanding 7.040M shares 7.040M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.03M $55.48M $55.48M
YoY Change 93289.05% 277292.57% 277300.0%
Cash & Equivalents $37.25K $57.28K $60.00K
Short-Term Investments $56.00M $55.42M $55.42M
Other Short-Term Assets $220.0K $220.0K $220.0K
YoY Change -15.38% -12.0% -12.0%
Inventory
Prepaid Expenses $222.1K $222.3K
Receivables
Other Receivables
Total Short-Term Assets $56.26M $55.70M $55.70M
YoY Change 17479.86% 20618.65% 20529.63%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $56.26M $55.70M $55.70M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $56.26M $55.70M $55.70M
YoY Change 17479.86% 20618.65% 20529.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.0K $140.0K $140.0K
YoY Change 180.0% 180.0%
Accrued Expenses $10.00K $10.00K $10.00K
YoY Change -79.14%
Deferred Revenue
YoY Change
Short-Term Debt $240.0K $0.00 $0.00
YoY Change -20.0% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.234M $2.831M $2.830M
YoY Change 977.85% 1040.29% 1032.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.234M $2.831M $2.830M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.234M $2.831M $2.830M
YoY Change 977.85% 1040.29% 1032.0%
SHAREHOLDERS EQUITY
Retained Earnings $311.5K $159.7K
YoY Change -3732.21%
Common Stock $163.00 $163.00
YoY Change 13.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 5.000M shares
Shareholders Equity $1.315M $5.299M $52.87M
YoY Change
Total Liabilities & Shareholders Equity $56.26M $55.70M $55.70M
YoY Change 17479.86% 20618.65% 20529.63%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $151.8K $170.0K $164.1K
YoY Change -7183.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$273.1K -$280.0K -$290.2K
YoY Change 11079.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $10.00K -$54.98M -$54.98M
YoY Change
Cash From Investing Activities $13.09K -$54.98M -$54.98M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $240.0K 55.31M $55.32M
YoY Change 444.7% -184466.67% 276475.09%
NET CHANGE
Cash From Operating Activities -$273.1K -280.0K -$290.2K
Cash From Investing Activities $13.09K -54.98M -$54.98M
Cash From Financing Activities $240.0K 55.31M $55.32M
Net Change In Cash -$20.04K 50.00K $40.42K
YoY Change -148.14% -266.67% 102.12%
FREE CASH FLOW
Cash From Operating Activities -$273.1K -$280.0K -$290.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40801
CY2022 dei Entity Registrant Name
EntityRegistrantName
AQUARON ACQUISITION CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2760193
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
515 Madison Avenue
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
8th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2022 dei City Area Code
CityAreaCode
(646)
CY2022 dei Local Phone Number
LocalPhoneNumber
970 2181
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
AQU
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7040240 shares
CY2022 dei Auditor Firm
AuditorFirmId
1195
CY2022 dei Auditor Name
AuditorName
UHY LLP
CY2022 dei Auditor Location
AuditorLocation
New York
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57284 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16860 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
222346 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
251984 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
55421229 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
55700859 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
268844 usd
CY2022Q4 us-gaap Assets
Assets
55700859 usd
CY2021Q4 us-gaap Assets
Assets
268844 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
99846 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
300 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
140075 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
47940 usd
CY2022Q4 aqu Franchise Tax Payable
FranchiseTaxPayable
13086 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
51753 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
200000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2525896 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2830656 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
248240 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2830656 usd
CY2021Q4 us-gaap Liabilities
Liabilities
248240 usd
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0.0001
CY2021Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
0.0001
CY2022Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
5417180 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
5417180 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
5417180 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
5417180 shares
CY2022Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
47571463 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
163 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
144 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5138905 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24856 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
159672 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4396 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5298740 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20604 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55700859 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
268844 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
207495 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4396 usd
CY2022 us-gaap Franchisor Costs
FranchisorCosts
13536 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-221031 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4396 usd
CY2022 us-gaap Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
259976 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
176876 usd
CY2022 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
215821 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-4396 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51753 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
164068 usd
us-gaap Net Income Loss
NetIncomeLoss
-4396 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20604 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
54171800 usd
CY2022 aqu Stock Issued During Period Value Sale Of Private Placement Units
StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits
2687654 usd
CY2022 aqu Stock Issued During Period Value Underwriter Commissions
StockIssuedDuringPeriodValueUnderwriterCommissions
-2708590 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-1465333 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
44011103 usd
CY2022 aqu Stock Issued During Period Value Accretion Of Common Stock To Redemption Value
StockIssuedDuringPeriodValueAccretionOfCommonStockToRedemptionValue
-3560360 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
164068 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5298740 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4396 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20604 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
164068 usd
us-gaap Net Income Loss
NetIncomeLoss
-4396 usd
CY2022 aqu Increase Decrease In Interest Earned On Investment Held In Trust Account
IncreaseDecreaseInInterestEarnedOnInvestmentHeldInTrustAccount
259976 usd
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
176876 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
222346 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-300 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
140075 usd
CY2022 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
13086 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
51753 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-290216 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4096 usd
CY2022 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
54984377 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54984377 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
54171800 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2687654 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100 usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
100000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
200000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
99546 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300000 usd
CY2022 aqu Payment Of Underwriters Commissions
PaymentOfUnderwritersCommissions
812577 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
631506 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
204044 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55315017 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20956 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40424 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16860 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16860 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57284 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16860 usd
CY2022 aqu Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
44011103 usd
CY2022 aqu Allocation Of Offering Costs To Common Stock Subject To Redemption
AllocationOfOfferingCostsToCommonStockSubjectToRedemption
3714253 usd
us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
47940000000 usd
CY2022 aqu Deferred Underwriting Commissions
DeferredUnderwritingCommissions
2525896 usd
CY2022 aqu Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
3560360 usd
CY2022Q4 us-gaap-sup Investment Unrestricted Purchase Price Date Per Unit
InvestmentUnrestrictedPurchasePriceDatePerUnit
10
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
750000 shares
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2022Q4 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
4171800 usd
CY2022Q4 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
125154 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5000001 usd
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
50000 usd
CY2022 aqu Trust Account Per Share
TrustAccountPerShare
10.15
CY2022Q4 us-gaap Cash
Cash
57284 usd
CY2022Q4 us-gaap Capital Units
CapitalUnits
39709 usd
CY2022 us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
25000 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
300000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.01 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.01 pure
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2022Q4 us-gaap Cash
Cash
57284 usd
CY2021Q4 us-gaap Cash
Cash
16860 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
55421229 usd
CY2022 aqu Interests Earned
InterestsEarned
436852 usd
CY2022 us-gaap Deferred Policy Acquisition Costs Text Block1
DeferredPolicyAcquisitionCostsTextBlock1
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred Offering Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs are allocated between public shares and public rights based on the estimated fair values of public shares and public rights at the date of issuance. Deferred offering costs were $3,955,624 and $251,984 consisting principally of underwriting, legal, accounting and other expenses incurred through December 31, 2022 and December 31, 2021, respectively, were charged to stockholders’ equity upon the completion of the IPO on October 6, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2022 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
-164068 usd
us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
4396 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3560360 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-3396292 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-4396 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2022 aqu Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
3560360 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
54171800 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6446444 usd
CY2022 aqu Allocation Of Offering Costs Related To Redeemable Shares
AllocationOfOfferingCostsRelatedToRedeemableShares
-3714253 usd
CY2022 aqu Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
3560360 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
47571463 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5000000 shares
CY2022Q4 us-gaap Share Price
SharePrice
10
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2022Q4 aqu Proceed From Issuance Initial Public Offering
ProceedFromIssuanceInitialPublicOffering
125154 usd
CY2021Q2 aqu Aggregate Price
AggregatePrice
25000 usd
CY2021Q2 aqu Share Issued And Outstanding Percentage
ShareIssuedAndOutstandingPercentage
0.20 pure
CY2022 aqu Subject To Certain Limited Exceptions Percentage
SubjectToCertainLimitedExceptionsPercentage
0.50 pure
CY2022Q4 us-gaap Repayments Of Debt
RepaymentsOfDebt
200000 usd
CY2022Q4 us-gaap Repayments Of Debt
RepaymentsOfDebt
100000 usd
CY2022 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
0 usd
us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
200000 usd
CY2023Q1 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
100000 usd
CY2023Q1 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
140000 usd
CY2022Q4 us-gaap Due To Other Related Parties Noncurrent
DueToOtherRelatedPartiesNoncurrent
99846 usd
CY2021Q4 us-gaap Due To Other Related Parties Noncurrent
DueToOtherRelatedPartiesNoncurrent
300 usd
CY2022 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
750000 shares
CY2022 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
812577 usd
CY2022 aqu Gross Proceeds
GrossProceeds
1896013 usd
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2022Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
100 usd
CY2022Q4 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
97509 shares
CY2022Q4 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
11.5
CY2022Q4 aqu Weighted Average Trading Price Of The Ordinary Shares
weightedAverageTradingPriceOfTheOrdinaryShares
1.15 pure
CY2022Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
10000000 shares
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.0001
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of the common stock are entitled to one vote for each share
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
187500 shares
aqu Initial Stockholders Percentage
InitialStockholdersPercentage
0.20 pure
CY2022Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
187500 shares
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1623060 shares
CY2022Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
1623060 shares
CY2022Q4 aqu Subject To Possible Redemption
SubjectToPossibleRedemption
5417180 shares
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
55421229 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
33997 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
924 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
37144 usd
CY2022Q4 aqu Deferred Taxs Asset Gross
DeferredTaxsAssetGross
-3147 usd
CY2021Q4 aqu Deferred Taxs Asset Gross
DeferredTaxsAssetGross
924 usd
CY2022Q4 aqu Deferred Tax Asset Valuation Allowances
DeferredTaxAssetValuationAllowances
-3147 usd
CY2021Q4 aqu Deferred Tax Asset Valuation Allowances
DeferredTaxAssetValuationAllowances
924 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
51753 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4071 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-924 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4071 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
924 usd
CY2022 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
51753 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2022 aqu Effective Income Tax Rate Reconciliation Change In Deferred Tax Transaction Costs Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxTransactionCostsAllowance
0.049 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.019 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
0.24 pure
us-gaap Effective Income Tax Rate Reconciliation Tax Credits Investment
EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment
0 pure
CY2022Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
4071 usd
CY2021Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
924 usd
CY2022 us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
51753 usd
us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2021Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
usd
CY2021Q4 aqu Franchise Tax Payable
FranchiseTaxPayable
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
usd
CY2021Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
aqu Increase Decrease In Interest Earned On Investment Held In Trust Account
IncreaseDecreaseInInterestEarnedOnInvestmentHeldInTrustAccount
usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
aqu Payment Of Underwriters Commissions
PaymentOfUnderwritersCommissions
usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
aqu Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
usd
aqu Allocation Of Offering Costs To Common Stock Subject To Redemption
AllocationOfOfferingCostsToCommonStockSubjectToRedemption
usd
CY2022 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
usd
aqu Deferred Underwriting Commissions
DeferredUnderwritingCommissions
usd
aqu Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2021Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001861063

Files In Submission

Name View Source Status
aqu-20221231_cal.xml Edgar Link unprocessable
0001213900-23-024748-index-headers.html Edgar Link pending
0001213900-23-024748-index.html Edgar Link pending
0001213900-23-024748.txt Edgar Link pending
0001213900-23-024748-xbrl.zip Edgar Link pending
aqu-20221231.xsd Edgar Link pending
f10k2022ex31-1_aquaronacq.htm Edgar Link pending
f10k2022ex31-2_aquaronacq.htm Edgar Link pending
f10k2022ex32-1_aquaronacq.htm Edgar Link pending
f10k2022ex32-2_aquaronacq.htm Edgar Link pending
f10k2022ex4-6_aquaronacq.htm Edgar Link pending
f10k2022_aquaronacq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
aqu-20221231_def.xml Edgar Link unprocessable
aqu-20221231_lab.xml Edgar Link unprocessable
aqu-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10k2022_aquaronacq_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending